Integrated Drug Substance-Drug Product development

Integrated Drug Substance-Drug Product development
Product Description

Process R&D, Custom manufacturing, formulation development, Clinical supplies, safety assessment

Syngene International Ltd.

  • IN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service

Syngene International Ltd.

  • IN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service

More Products from Syngene International Ltd. (4)

  • Small & large molecule Discovery & Development

    Product Small & large molecule Discovery & Development

    Discovery Chemistry, Discovery Biology, Integrated Drug Discovery
  • Clinical supplies

    Product Clinical supplies

    Syngene International Ltd. provides wide range of services which includes clinical supplies. It belongs to formulation development services category. It includes scale range - 0.1 kg to 50 kg, packaging - bottles and blister packing. Contact us for more information.
  • Antibody Drug Conjugates

    Product Antibody Drug Conjugates

    Syngene’s Antibody Drug Conjugate (ADC) unit brings together an array of multidisciplinary capabilities in antibody generation, linker and payload chemistry, conjugation chemistry, in vitro and in vivo oncology in an integrated platform.
  • Oligonucleotide Synthesis

    Product Oligonucleotide Synthesis

    Syngene’s Oligonucleotide capacity & services ranges from development to cGMP manufacturing of chemically synthesized high quality modified and non-modified custom Oligonucleotide (DNA/RNA), siRNA (single & double stranded, miRNA (modified and non-modified), Antisense, fast delivery of Oligonucleot...

Syngene International Ltd. resources (2)